Free Trial

Quest Partners LLC Purchases 22,181 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

Quest Partners LLC lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 200.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,256 shares of the company's stock after purchasing an additional 22,181 shares during the quarter. Quest Partners LLC's holdings in Bath & Body Works were worth $1,062,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Principal Financial Group Inc. raised its stake in shares of Bath & Body Works by 328.7% during the third quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock valued at $34,153,000 after purchasing an additional 820,379 shares in the last quarter. UniSuper Management Pty Ltd raised its position in Bath & Body Works by 576.9% in the first quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company's stock worth $1,140,000 after acquiring an additional 19,431 shares in the last quarter. New York State Teachers Retirement System raised its position in Bath & Body Works by 18.1% in the third quarter. New York State Teachers Retirement System now owns 266,235 shares of the company's stock worth $8,498,000 after acquiring an additional 40,793 shares in the last quarter. Renaissance Technologies LLC raised its position in Bath & Body Works by 152.7% in the second quarter. Renaissance Technologies LLC now owns 901,133 shares of the company's stock worth $35,189,000 after acquiring an additional 544,599 shares in the last quarter. Finally, Los Angeles Capital Management LLC raised its position in Bath & Body Works by 404.4% in the third quarter. Los Angeles Capital Management LLC now owns 134,544 shares of the company's stock worth $4,295,000 after acquiring an additional 107,868 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on BBWI shares. Deutsche Bank Aktiengesellschaft dropped their price target on Bath & Body Works from $57.00 to $54.00 and set a "buy" rating on the stock in a research note on Monday, August 26th. Morgan Stanley dropped their price target on Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating on the stock in a research note on Thursday, September 5th. JPMorgan Chase & Co. decreased their price objective on Bath & Body Works from $42.00 to $39.00 and set a "neutral" rating for the company in a research report on Thursday, August 29th. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $60.00 to $49.00 and set a "buy" rating for the company in a research report on Thursday, August 29th. Finally, Bank of America lowered their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a "buy" rating on the stock in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, Bath & Body Works has an average rating of "Moderate Buy" and an average price target of $42.44.

Check Out Our Latest Stock Analysis on BBWI

Bath & Body Works Trading Up 0.3 %

Shares of BBWI opened at $30.52 on Thursday. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The stock has a 50 day simple moving average of $30.41 and a 200-day simple moving average of $36.14. The stock has a market cap of $6.69 billion, a PE ratio of 7.39, a PEG ratio of 0.97 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The business had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.54 billion. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.62%. Bath & Body Works's dividend payout ratio (DPR) is presently 19.37%.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Recommended Stories

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Should you invest $1,000 in Bath & Body Works right now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines